Cytocell launches Chromosome Multiprobe system:
This article was originally published in Clinica
Cytocell (UK) has introduced the Chromoprobe Multiprobe system, a disposable kit which uses chromosome paints to detect complex abnormalities on all 24 chromosomes simultaneously on a single slide. Since the chromosome probes are directly labelled, lengthy post-hybridisation amplification steps are often not necessary, Cytocell says. The company has applied for patent coverage for the technology used in the kit. It is also developing another Multiprobe kit for chromosome enumeration in leukaemia cytogenetics. The Multiprobe system was originally developed by the Department of Biochemistry at Oxford University and Oxford's Churchill Hospital.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.